
MeiraGTx Holdings PLC
MGTXHealthcare|Biotechnology|USA
$13.38
-0.56 (-3.98%)
Analyst Estimates
annual
{
"date": [
"202612",
"202712",
"202812",
"202912",
"203012"
],
"revenue_estimate": [
49.75,
143.57,
100.11,
265.59,
557.77
],
"ebit_estimate": [
-149.08,
-164.03,
-129.39,
-46.04,
81.44
],
"ebitda_estimate": [
3.81,
-142.34,
null,
null,
null
],
"net_income_estimate": [
-165.13,
-188.74,
-179.88,
-157.8,
114.09
],
"per_share_eps_estimate": [
-1.61,
-1.91,
-1.75,
-0.56,
1.08
],
"eps_nri_estimate": [
-1.61,
-1.92,
-1.78,
-0.56,
1.08
],
"dividend_estimate": [
null,
null,
null,
null,
null
],
"book_value_per_share_estimate": [
null,
null,
null,
null,
null
],
"pretax_income_estimate": [
-164.4,
-190.34,
-179.88,
-59.75,
127.91
],
"operating_cash_flow_per_share_estimate": [
0.55,
-1.43,
null,
null,
null
],
"roa_estimate": [
null,
null,
null,
null,
null
],
"roe_estimate": [
-17.8,
null,
null,
null,
null
],
"gross_margin_estimate": [
null,
null,
null,
null,
null
],
"operating_cash_flow_estimate": [
44.72,
-116.26,
null,
null,
null
],
"pettm_estimate": [
0,
0,
0,
0,
12.39
],
"long_term_growth_rate_mean": -8.86,
"long_term_revenue_growth_rate_mean": "0.00",
"future_per_share_eps_estimate_growth": -8.32,
"future_eps_nri_estimate_growth": -8.86,
"future_revenue_estimate_growth": null,
"future_ebit_estimate_growth": null,
"future_ebitda_estimate_growth": null,
"future_dividend_estimate_growth": null,
"future_net_income_estimate_growth": -16.14,
"future_pretax_income_estimate_growth": -16.29,
"future_book_value_per_share_estimate_growth": null,
"future_roa_estimate_growth": null,
"future_roe_estimate_growth": null,
"future_gross_margin_estimate_growth": null,
"future_operating_cash_flow_per_share_estimate_growth": null
}
quarterly
{
"date": [
"202606",
"202609",
"202612",
"202703",
"202706",
"202709",
"202712"
],
"revenue_estimate": [
24.83,
6.84,
30.46,
1.03,
1.03,
1.35,
86.33
],
"ebit_estimate": [
-34,
-45.69,
-28.88,
-44.69,
-48.09,
-50.75,
-56.18
],
"ebitda_estimate": [
15.02,
-42.72,
69.12,
null,
null,
null,
null
],
"net_income_estimate": [
-39.78,
-47.94,
-31.14,
-47.69,
-51.27,
-54.1,
-60.25
],
"per_share_eps_estimate": [
-0.31,
-0.51,
-0.35,
-0.51,
-0.53,
-0.56,
-0.58
],
"eps_nri_estimate": [
-0.31,
-0.51,
-0.35,
-0.51,
-0.53,
-0.56,
-0.58
],
"dividend_estimate": [
null,
null,
null,
null,
null,
null,
null
],
"book_value_per_share_estimate": [
null,
null,
null,
null,
null,
null,
null
],
"pretax_income_estimate": [
-47.74,
-49.06,
-51.8,
-46.41,
-49.97,
-52.79,
-60.25
],
"operating_cash_flow_per_share_estimate": [
null,
null,
null,
null,
null,
null,
null
],
"roa_estimate": [
null,
null,
null,
null,
null,
null,
null
],
"roe_estimate": [
null,
null,
null,
null,
null,
null,
null
],
"gross_margin_estimate": [
null,
null,
null,
null,
null,
null,
null
],
"operating_cash_flow_estimate": [
null,
null,
null,
null,
null,
null,
null
],
"pettm_estimate": [
0,
0,
0,
0,
null,
null,
null
],
"long_term_growth_rate_mean": -8.86,
"long_term_revenue_growth_rate_mean": "0.00",
"future_per_share_eps_estimate_growth": -8.32,
"future_eps_nri_estimate_growth": -8.86,
"future_revenue_estimate_growth": null,
"future_ebit_estimate_growth": null,
"future_ebitda_estimate_growth": null,
"future_dividend_estimate_growth": null,
"future_net_income_estimate_growth": -16.14,
"future_pretax_income_estimate_growth": -16.29,
"future_book_value_per_share_estimate_growth": null,
"future_roa_estimate_growth": null,
"future_roe_estimate_growth": null,
"future_gross_margin_estimate_growth": null,
"future_operating_cash_flow_per_share_estimate_growth": null
}